SIRT1 mediates the antagonism of Wnt/β-catenin pathway by vitamin D in colon carcinoma cells

José Manuel García-Martínez,Ana Chocarro-Calvo,Javier Martínez-Useros,Nerea Regueira-Acebedo,María Jesús Fernández-Aceñero,Alberto Muñoz,María Jesús Larriba,Custodia García-Jiménez

DOI: https://doi.org/10.1101/2024.01.21.576539

2024-01-24

Abstract:Cancer initiation and progression result from both genetic alterations and epigenetic reprograming caused by environmental or endogenous factors which can lead to aberrant cell signalling. Most colorectal cancers (CRC) are linked to the abnormal activation of the Wnt/ β-catenin pathway, whose key feature is the accumulation of acetylated β-catenin protein within the nucleus of colon epithelial cells. Nuclear β- catenin acts as a transcriptional co-activator that alters the expression of many target genes involved in cell proliferation and invasion. The most active vitamin D metabolite 1,25-dihydroxyvitamin D3 (1,25(OH)2D3, calcitriol) can antagonize the over-activated Wnt/ β-catenin pathway via binding to its high affinity receptor VDR. Here, we show that the activation of the SIRT1 deacetylase by 1,25(OH)2D3-bound VDR promotes deacetylation and nuclear exclusion of β-catenin and, consequently, the downregulation of its pro-tumorigenic target genes and the inhibition of human colon carcinoma cell proliferation. Notably, orthogonal SIRT1 activation systematically drives nuclear exclusion of β-catenin, highlighting the key role of SIRT1 in CRC. Since nuclear localization of β-catenin is a critical driver of CRC initiation and progression that requires its acetylation, our results provide a mechanistic basis for the epidemiological evidence linking vitamin D deficiency and increased CRC risk and mortality.

Cancer Biology

What problem does this paper attempt to address?

This paper aims to explore how vitamin D counteracts the abnormal activation of the Wnt/β - catenin signaling pathway in colon cancer cells by regulating SIRT1. Specifically, the study focused on how the active vitamin D metabolite 1,25 - dihydroxyvitamin D3 (1,25(OH)2D3) binds to the vitamin D receptor (VDR) to promote the activation of SIRT1 deacetylase, which in turn leads to the deacetylation and nuclear exclusion of β - catenin, and ultimately down - regulates the expression of its pro - tumorigenic target genes, inhibiting the proliferation of human colon cancer cells. In addition, the paper also explored the relationship between SIRT1 activity and the level of nuclear β - catenin, and proposed the possibility of inhibiting the Wnt/β - catenin signaling pathway by targeting SIRT1 activity in the case of 1,25(OH)2D3 non - responsiveness.

The key point of the paper is to reveal the central role of SIRT1 in the 1,25(OH)2D3 - mediated inhibition of the Wnt/β - catenin signaling pathway, which not only provides a mechanistic basis for understanding the epidemiological link between vitamin D deficiency and increased colon cancer risk, but also provides theoretical support for the development of new treatment strategies.